133 related articles for article (PubMed ID: 38198960)
1. Human umbilical cord-derived mesenchymal stem cells ameliorate liver fibrosis by improving mitochondrial function via Slc25a47-Sirt3 signaling pathway.
Chen P; Yuan M; Yao L; Xiong Z; Liu P; Wang Z; Jiang Y; Li L
Biomed Pharmacother; 2024 Feb; 171():116133. PubMed ID: 38198960
[TBL] [Abstract][Full Text] [Related]
2. Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis.
Yuan M; Yao L; Chen P; Wang Z; Liu P; Xiong Z; Hu X; Li L; Jiang Y
Int Immunopharmacol; 2023 Dec; 125(Pt A):111134. PubMed ID: 37918086
[TBL] [Abstract][Full Text] [Related]
3. Human umbilical cord-derived mesenchymal stromal cells alleviate liver cirrhosis through the Hippo/YAP/Id1 pathway and macrophage-dependent mechanism.
Yao L; Hu X; Yuan M; Liu P; Zhang Q; Wang Z; Chen P; Xiong Z; Wu L; Dai K; Jiang Y
Int Immunopharmacol; 2023 Oct; 123():110456. PubMed ID: 37494836
[TBL] [Abstract][Full Text] [Related]
4.
Zhang GZ; Sun HC; Zheng LB; Guo JB; Zhang XL
World J Gastroenterol; 2017 Dec; 23(46):8152-8168. PubMed ID: 29290652
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway.
Zhou Q; Rong C; Gu T; Li H; Wu L; Zhuansun X; Zhao X; Xiao Z; Kuang Y; Xu S; Wang S
Stem Cell Res Ther; 2022 Jul; 13(1):354. PubMed ID: 35883205
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment of UC-MSCs with IFN-α2 improves treatment of liver fibrosis by recruiting neutrophils.
Xie Y; Yao J; Yan M; Lin Y; Wei J; Wang H; Mao Y; Liu P; Li X
J Transl Med; 2023 Nov; 21(1):832. PubMed ID: 37980535
[TBL] [Abstract][Full Text] [Related]
7. Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2/NQO-1 pathway.
Kang Y; Song Y; Luo Y; Song J; Li C; Yang S; Guo J; Yu J; Zhang X
Free Radic Biol Med; 2022 Nov; 192():25-36. PubMed ID: 36096356
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem Cells Attenuate Diabetic Lung Fibrosis via Adjusting Sirt3-Mediated Stress Responses in Rats.
Chen Y; Zhang F; Wang D; Li L; Si H; Wang C; Liu J; Chen Y; Cheng J; Lu Y
Oxid Med Cell Longev; 2020; 2020():8076105. PubMed ID: 32089781
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice.
Nasir GA; Mohsin S; Khan M; Shams S; Ali G; Khan SN; Riazuddin S
J Transl Med; 2013 Mar; 11():78. PubMed ID: 23531302
[TBL] [Abstract][Full Text] [Related]
10. Human mesenchymal stem cells derived from adipose tissue showed a more robust effect than those from the umbilical cord in promoting corneal graft survival by suppressing lymphangiogenesis.
Kang H; Feng J; Peng Y; Liu Y; Yang Y; Wu Y; Huang J; Jie Y; Chen B; He Y
Stem Cell Res Ther; 2023 Nov; 14(1):328. PubMed ID: 37957770
[TBL] [Abstract][Full Text] [Related]
11. A novel minimally invasive OFM technique with orthotopic transplantation of hUC-MSCs and in vivo monitoring of liver metabolic microenvironment in liver fibrosis treatment.
Yang H; Xie Y; Li T; Liu S; Zeng S; Wang B
Stem Cell Res Ther; 2021 Oct; 12(1):534. PubMed ID: 34627378
[TBL] [Abstract][Full Text] [Related]
12. TC14012 enhances the anti-fibrosis effects of UC-MSCs on the liver by reducing collagen accumulation and ameliorating inflammation.
Ding F; Liu Y; Li J; Wei X; Zhao J; Liu X; Zhang L
Stem Cell Res Ther; 2024 Feb; 15(1):44. PubMed ID: 38360740
[TBL] [Abstract][Full Text] [Related]
13. Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1/Stat3 signaling.
He Y; Guo X; Lan T; Xia J; Wang J; Li B; Peng C; Chen Y; Hu X; Meng Z
Stem Cell Res Ther; 2021 Jul; 12(1):396. PubMed ID: 34256837
[TBL] [Abstract][Full Text] [Related]
14. Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K/AKT signaling pathway.
Aierken A; Li B; Liu P; Cheng X; Kou Z; Tan N; Zhang M; Yu S; Shen Q; Du X; Enkhbaatar BB; Zhang J; Zhang R; Wu X; Wang R; He X; Li N; Peng S; Jia W; Wang C; Hua J
Stem Cell Res Ther; 2022 Apr; 13(1):164. PubMed ID: 35414044
[TBL] [Abstract][Full Text] [Related]
15. Anti-TGFβ-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGFβ-1/Smad pathway.
Xuan J; Feng W; An ZT; Yang J; Xu HB; Li J; Zhao ZF; Wen W
Mol Cell Biochem; 2017 May; 429(1-2):113-122. PubMed ID: 28181132
[TBL] [Abstract][Full Text] [Related]
16. Dynamic microRNA profiles of hepatic differentiated human umbilical cord lining-derived mesenchymal stem cells.
Cui L; Zhou X; Li J; Wang L; Wang J; Li Q; Chu J; Zheng L; Wu Q; Han Z; Shi Y; Han Y; Fan D
PLoS One; 2012; 7(9):e44737. PubMed ID: 22984549
[TBL] [Abstract][Full Text] [Related]
17. Human umbilical cord mesenchymal stem cells combined with pirfenidone upregulates the expression of RGS2 in the pulmonary fibrosis in mice.
Wu X; Gou H; Zhou O; Qiu H; Liu H; Fu Z; Chen L
Respir Res; 2022 Oct; 23(1):270. PubMed ID: 36182915
[TBL] [Abstract][Full Text] [Related]
18. Human umbilical cord mesenchymal stem cells attenuate diet-induced obesity and NASH-related fibrosis in mice.
Hu J; Li S; Zhong X; Wei Y; Sun Q; Zhong L
Heliyon; 2024 Feb; 10(3):e25460. PubMed ID: 38356602
[TBL] [Abstract][Full Text] [Related]
19. Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis
Yin F; Wang WY; Jiang WH
World J Stem Cells; 2019 Aug; 11(8):548-564. PubMed ID: 31523373
[TBL] [Abstract][Full Text] [Related]
20. Secretome of Hypoxia-Preconditioned Mesenchymal Stem Cells Promotes Liver Regeneration and Anti-Fibrotic Effect in Liver Fibrosis Animal Model.
Amansyah F; Budu B; Achmad MH; Daud NMAS; Putra A; Massi MN; Bukhari A; Hardjo M; Parewangi L; Patellongi I
Pak J Biol Sci; 2024 Jan; 27(1):18-26. PubMed ID: 38413394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
